Sabra Healthcare Reit Stock Return On Equity
| SBRA Stock | USD 19.67 0.12 0.61% |
Sabra Healthcare REIT fundamentals help investors to digest information that contributes to Sabra Healthcare's financial success or failures. It also enables traders to predict the movement of Sabra Stock. The fundamental analysis module provides a way to measure Sabra Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sabra Healthcare stock.
| Last Reported | Projected for Next Year |
Sabra | Return On Equity |
Sabra Healthcare REIT Company Return On Equity Analysis
Sabra Healthcare's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sabra Healthcare Return On Equity | 0.0346 |
Most of Sabra Healthcare's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sabra Healthcare REIT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Sabra Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Sabra Healthcare is extremely important. It helps to project a fair market value of Sabra Stock properly, considering its historical fundamentals such as Return On Equity. Since Sabra Healthcare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sabra Healthcare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sabra Healthcare's interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Sabra Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Sabra Healthcare REIT has a Return On Equity of 0.0346. This is 102.54% lower than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The return on equity for all United States stocks is 111.16% lower than that of the firm.
Sabra Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sabra Healthcare's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sabra Healthcare could also be used in its relative valuation, which is a method of valuing Sabra Healthcare by comparing valuation metrics of similar companies.Sabra Healthcare is currently under evaluation in return on equity category among its peers.
Sabra Healthcare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Sabra Healthcare from analyzing Sabra Healthcare's financial statements. These drivers represent accounts that assess Sabra Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Sabra Healthcare's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 4.0B | 3.6B | 3.0B | 2.9B | 3.3B | 3.5B | |
| Enterprise Value | 6.4B | 5.9B | 5.2B | 5.5B | 5.7B | 3.2B |
Sabra Healthcare ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Sabra Healthcare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Sabra Healthcare's managers, analysts, and investors.Environmental | Governance | Social |
Sabra Fundamentals
| Return On Equity | 0.0346 | ||||
| Return On Asset | 0.0283 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.36 % | ||||
| Current Valuation | 7.06 B | ||||
| Shares Outstanding | 236.59 M | ||||
| Shares Owned By Insiders | 1.16 % | ||||
| Shares Owned By Institutions | 96.74 % | ||||
| Number Of Shares Shorted | 19.65 M | ||||
| Price To Earning | 67.37 X | ||||
| Price To Book | 1.69 X | ||||
| Price To Sales | 6.81 X | ||||
| Revenue | 655.85 M | ||||
| Gross Profit | 372.8 M | ||||
| EBITDA | 418.15 M | ||||
| Net Income | 13.76 M | ||||
| Cash And Equivalents | 49.05 M | ||||
| Cash Per Share | 0.21 X | ||||
| Total Debt | 2.45 B | ||||
| Debt To Equity | 0.76 % | ||||
| Current Ratio | 0.78 X | ||||
| Book Value Per Share | 11.60 X | ||||
| Cash Flow From Operations | 301.12 M | ||||
| Short Ratio | 9.95 X | ||||
| Earnings Per Share | 0.41 X | ||||
| Price To Earnings To Growth | 3.15 X | ||||
| Target Price | 19.32 | ||||
| Number Of Employees | 48 | ||||
| Beta | 1.24 | ||||
| Market Capitalization | 4.65 B | ||||
| Total Asset | 5.39 B | ||||
| Retained Earnings | (1.72 B) | ||||
| Working Capital | 311.89 M | ||||
| Current Asset | 17.25 M | ||||
| Current Liabilities | 35.18 M | ||||
| Annual Yield | 0.06 % | ||||
| Five Year Return | 9.02 % | ||||
| Net Asset | 5.39 B | ||||
| Last Dividend Paid | 1.2 |
About Sabra Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sabra Healthcare REIT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sabra Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sabra Healthcare REIT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:Check out Sabra Healthcare Piotroski F Score and Sabra Healthcare Altman Z Score analysis. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.111 | Dividend Share 1.2 | Earnings Share 0.41 | Revenue Per Share 2.943 | Quarterly Revenue Growth 0.107 |
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.